Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis

NCT01459393 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.

NCT NCT01459393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis
Lead sponsor
Barretos Cancer Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
November 30, 2011
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis